Beena Goldenberg: I think to start with, we continue to look at ways to enhance our yields further. So even with the completion of our expansion build out in Moncton, so the LED lights only roll through all of our facility by the end of this past quarter. And so the full impact of that benefit isn’t yet in our numbers. As I mentioned and as I was talking, fractional watering will only be complete through the end of the calendar year. So that benefit is still to come and we work with our plant science group, the, the work that they’re doing on cultivars, uh, breeding, cross breeding and selection. We’re finding cultivars that have higher yields and higher potencies and will continue to update our garden with those products. So, there is upside even to the 85,000 kilograms that we’re talking about right now as we work through the fiscal year at our Moncton facility.
With that being said, and as you also mentioned, we have the capacity at the ranching facility. There is always the opportunity to go out into the market and buy incremental flower as required to fulfill our pro our sales needs. We don’t anticipate needing it for fiscal year ’23 based on sales, but if opportunities come up, we can certainly look at that there is excess capacity in the marketplace. And again that will be buying product that meets the specifications that we need to have to meet our consumers demand and the quality of products they’re looking for from us.
Michael Freeman: And if I didn’t just drop, I have another question. Thank you for that answer. Talking about the categories in which you play OrganiGram has been in dominant and far very strong in edibles. The number two and three most important areas, largest categories apart from these or largest categories in the nation are pre-rolls and vapes after that, in which, by my calculations, OrganiGram stands number 9 and number 12 position respectively among LPs? How is OrganiGram thinking about these categories? I recognize there’s an increased attention put towards vapes? Recently, we saw some positive movement there. How can OrganiGram cultivate a right to win in each of each of those categories, if these our aims?
Beena Goldenberg: So, I think, a couple of answers here. Look, it’s always important to look at all the different categories and where there’s new opportunities for growth. Certainly, pre-roll is one that we have been and we have held higher market positions than where we are. And at the end of the day, no different than our flower demand in fiscal 2022, we had demand that outstripped our supply. And so we were at fully pushing on our pre-roll opportunities. Now that our flower is coming in, we have more opportunity to expand our pre-roll offering and we will continue to do so. So we have a strong pre-roll offering under our SHRED brand, called Jar of Joints. And we have a really good product offering under our Edison brand.
Our Pinners that are dual. We have dual flavored, dual strain offerings under Edison. So we have good competing offerings. We just haven’t been pushing pre-rolls to the extent, as a result of our available capacity and that will change going into fiscal year ’23 as we have more flower available. In terms of vapes, as you said, we were not really a player in the vape market. We introduced vapes under our SHRED-X brand, again leveraging our brand strength and saw very strong off take at the beginning. Now we have to find, make sure that, we are offering a product that meets both what consumers are looking for at the right price. And it’s a very crowded space in vapes right now and the market is very highly competitive. So while we have something to offer that’s unique and different, we are in there and we do believe, but offering flavors that match our very successful flower flavors for our SHRED milled flower that we had something unique to offer in the marketplace.
